NOVO-B.CO vs. HBAR-USD
NOVO-B.CO (Novo Nordisk A/S) is a stock, while HBAR-USD (HederaHashgraph) is a cryptocurrency. Over the past 5 years, NOVO-B.CO returned 20.64%/yr vs -16.10%/yr for HBAR-USD. At a 0.07 correlation, their price movements are largely independent.
Performance
NOVO-B.CO vs. HBAR-USD - Performance Comparison
Loading charts...
Different Trading Currencies
NOVO-B.CO is traded in DKK, while HBAR-USD is traded in USD. To make them comparable, the HBAR-USD values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -8.64% return, which is significantly higher than HBAR-USD's -25.18% return.
NOVO-B.CO
- 1D
- 1.66%
- 1M
- -3.99%
- YTD
- -8.64%
- 6M
- -7.47%
- 1Y
- -41.76%
- 3Y*
- 4.58%
- 5Y*
- 20.64%
- 10Y*
- 17.36%
HBAR-USD
- 1D
- 0.00%
- 1M
- -16.95%
- YTD
- -25.18%
- 6M
- -35.95%
- 1Y
- -50.81%
- 3Y*
- 17.41%
- 5Y*
- -16.10%
- 10Y*
- —
NOVO-B.CO vs. HBAR-USD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | -8.64% | -46.40% | -9.59% | 205.34% | 31.49% | 79.08% | 15.29% | 15.76% |
HBAR-USD HederaHashgraph | -25.18% | -65.08% | 220.92% | 131.17% | -86.28% | 879.66% | 184.69% | -97.57% |
Correlation
The correlation between NOVO-B.CO and HBAR-USD is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Sep 17, 2019 | 0.07 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOVO-B.CO vs. HBAR-USD — Risk / Return Rank
NOVO-B.CO
HBAR-USD
NOVO-B.CO vs. HBAR-USD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and HederaHashgraph (HBAR-USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOVO-B.CO | HBAR-USD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.13 | ||
| Sortino ratioReturn per unit of downside risk | -0.11 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 0.92 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | -0.69 | -0.09 |
| Martin ratioReturn relative to average drawdown | -1.15 | -0.99 | -0.16 |
Loading charts...
Drawdowns
NOVO-B.CO vs. HBAR-USD - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -76.75%, smaller than the maximum HBAR-USD drawdown of -97.60%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and HBAR-USD.
Loading charts...
Drawdown Indicators
| NOVO-B.CO | HBAR-USD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.75% | -97.60% | +20.85% |
Max Drawdown (1Y)Largest decline over 1 year | -54.63% | -73.29% | +18.66% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -81.83% | +5.08% |
Max Drawdown (5Y)Largest decline over 5 years | -76.75% | -91.82% | +15.07% |
Max Drawdown (10Y)Largest decline over 10 years | -76.75% | — | — |
Current DrawdownCurrent decline from peak | -70.15% | -84.13% | +13.98% |
Average DrawdownAverage peak-to-trough decline | -11.29% | -73.72% | +62.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.11% | 51.58% | -14.47% |
Volatility
NOVO-B.CO vs. HBAR-USD - Volatility Comparison
The current volatility for Novo Nordisk A/S (NOVO-B.CO) is 11.47%, while HederaHashgraph (HBAR-USD) has a volatility of 15.09%. This indicates that NOVO-B.CO experiences smaller price fluctuations and is considered to be less risky than HBAR-USD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOVO-B.CO | HBAR-USD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.47% | 15.09% | -3.62% |
Volatility (6M)Calculated over the trailing 6-month period | 39.57% | 43.18% | -3.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.40% | 65.04% | -10.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.56% | 84.27% | -25.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.08% | 108.01% | -62.93% |
Frequently Asked Questions
NOVO-B.CO and HBAR-USD have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOVO-B.CO and HBAR-USD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer